NIEHS joined with the National Heart, Lung, and Blood Institute (NHLBI) to support research that showed reducing exposure to lead in American Indian populations can improve heart health. The paper…
Chelation therapy does not reduce the occurrence of major adverse cardiovascular events in patients with diabetes who have had a heart attack, according to a multicenter clinical trial funded by…
For adults with elevated cardiometabolic risk who usually slept for at least 7 hours per night, body weight increased by 1 lb over 6 weeks when they lost 1.5 hours…
Well known for his influential work on the neurotoxicity of low-level lead exposure, Bruce Lanphear, M.D., said he now believes storytelling is the most critical tool we need to protect…
NIEHS Director Rick Woychik, Ph.D., has announced his selection of Michael Fessler, M.D., as the permanent Clinical Director of NIEHS effective Dec. 29, 2024. “Dr. Fessler’s unique combination of clinical…
Kiyo Gomi.BOSTON—Eyebot, developer of automated vision testing kiosks that offer doctor-verified eyeglass prescriptions, has appointed long-standing team member Kiyo Gomi to the role of chief operating officer, the…
Walsh named NIEHS Director. (Photo courtesy of Steve McCaw / NIEHS) Kyle Walsh, Ph.D., was selected as the new director of NIEHS, which is part of the National Institutes of…
Compare health Insurance & supplemental plans from trusted insurance providers. Get personalized quotes in minutes and speak with a licensed agent today.
Enter your ZIP code to see plans available in your area.
